CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

NEW
FRA:1CG (Switzerland)   Ordinary Shares
€ 42.2 +0.20 (+0.49%) Jul 31
At Loss
P/B:
2.55
Market Cap:
€ 4.10B ($ 4.73B)
Enterprise V:
€ 2.67B ($ 3.07B)
Volume:
50.00
Avg Vol (2M):
265.00
Trade In:
Buying
0 ( 0 % )
To
Top 10 Stocks in Buying
Stock Votes
Not interested
0 ( 0 % )
To
Top 10 Stocks in Not interested
Stock Votes
Comments